Company / Book Value per Share
Seres Therapeutics, Inc. Book Value per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.593
FY2025
5-year range
-$0.685 / $1.902
FY2021-FY2025
Trend
+51.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has fluctuated over the past 10 years, ranging from -$1.613 in FY2015 to $5.09 in FY2017.
Based on SEC 10-K filings.
$1.593 in FY2025 with a 3-year CAGR of -5.7%.
Declined from $1.902 to $1.593 over the past 3 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -5.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -5.7%, indicating a declining trend.
- In FY2025, book value per share increased 51.7% year-over-year.
- Peak book value per share was recorded in FY2017.
- Lowest book value per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.593 | +51.7% |
| FY2023 | $1.05 | -44.8% |
| FY2022 | $1.902 | +459.9% |
| FY2021 | -$0.528 | +22.9% |
| FY2020 | -$0.685 | -146.2% |
| FY2019 | $1.483 | -54.6% |
| FY2018 | $3.269 | -35.8% |
| FY2017 | $5.09 | +844.4% |
| FY2016 | -$0.684 | +57.6% |
| FY2015 | -$1.613 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026